1
|
Guo S, Liu L, Zou C, Liang P, Wang Y, Sun C, Gan X, Tian X, Yuan L. Correlation between parathyroid volume and calcium and phosphorus metabolism in maintenance hemodialysis patients based on Doppler ultrasound technology. Int Urol Nephrol 2025:10.1007/s11255-025-04561-8. [PMID: 40374815 DOI: 10.1007/s11255-025-04561-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2025] [Accepted: 04/28/2025] [Indexed: 05/18/2025]
Abstract
OBJECTIVES To investigate the correlation between parathyroid glands (PTGs) volume and calcium and phosphorus metabolism in maintenance hemodialysis (MHD) patients with Doppler ultrasound. METHODS MHD patients at the Hemodialysis Center of the Third Affiliated Hospital of Zunyi Medical University from January 1, 2024, to January 31, 2024, were selected as study subjects. To investigate the correlation between the number and size of PTGs detected by bedside ultrasound and indicators of calcium and phosphorus metabolism. RESULTS A total of 135 patients were included, of whom 90 had explored hyperplastic PTGs and 45 did not. Correlation analysis showed a negative correlation between ultrasound total PTGs volume and with age (r = -0.222, P = 0.035), large platelet ratio (r = -0.262, P = 0.013), and mean platelet volume (r = -0.232, P = 0.028), and a positive correlation with parathyroid hormone (iPTH) (r = 0.268, P = 0.011), corrected serum calcium (r = 0.233, P = 0.027), taking cinacalcet (r = 0.252, P = 0.0.017), sevelamer carbonate (r = 0.352, P = 0.002) and compound α-ketoacid tablets (r = 0.478, P < 0.001). Multifactorial linear regression analysis showed a positive correlation between ultrasound total PTGs volume and the correlation with age (t = -3.071, 95% CI: -0.030 ~ -0.007), albumin (t = -2.242, 95% CI: -0.115 ~ -0.008), iPTH (t = 2.748, 95% CI: 0.001 ~ 0.002), corrected serum calcium (t = 2.484, 95% CI: 0.184 ~ 1.563) showed significant linear relationships. CONCLUSIONS A significant linear correlation was observed between PTGs volume, assessed via Doppler ultrasound, and the variables of age, albumin, iPTH, and corrected serum calcium in MHD patients. Therefore, it is essential for MHD patients to be closely monitored and have these serological indices controlled.
Collapse
Affiliation(s)
- Shengjie Guo
- Department of Nephrology, Third Affiliated Hospital of Zunyi Medical University (First People's Hospital of Zunyi), 98 Fenghuang North Road, Zunyi, 563000, Guizhou, China
| | - Liping Liu
- Department of Nephrology, Third Affiliated Hospital of Zunyi Medical University (First People's Hospital of Zunyi), 98 Fenghuang North Road, Zunyi, 563000, Guizhou, China
| | - Chao Zou
- Department of Nephrology, Third Affiliated Hospital of Zunyi Medical University (First People's Hospital of Zunyi), 98 Fenghuang North Road, Zunyi, 563000, Guizhou, China
| | - Pingping Liang
- Department of Nephrology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China
| | - Yurou Wang
- Department of Nephrology, Qian Xi Nan People's Hospital, Xingyi, Guizhou, China
| | - Chengcheng Sun
- Department of Nephrology, Third Affiliated Hospital of Zunyi Medical University (First People's Hospital of Zunyi), 98 Fenghuang North Road, Zunyi, 563000, Guizhou, China
| | - Xiaosu Gan
- Department of Nephrology, Third Affiliated Hospital of Zunyi Medical University (First People's Hospital of Zunyi), 98 Fenghuang North Road, Zunyi, 563000, Guizhou, China
| | - Xiaofang Tian
- Department of Nephrology, Third Affiliated Hospital of Zunyi Medical University (First People's Hospital of Zunyi), 98 Fenghuang North Road, Zunyi, 563000, Guizhou, China.
| | - Liying Yuan
- Department of Nephrology, Third Affiliated Hospital of Zunyi Medical University (First People's Hospital of Zunyi), 98 Fenghuang North Road, Zunyi, 563000, Guizhou, China.
| |
Collapse
|
2
|
Palamar M, Grosu ID, Schiller A, Petrica L, Bodea M, Sircuta A, Gruescu E, Matei OD, Tanasescu MD, Golet I, Bob F. Vitamin K-Dependent Proteins as Predictors of Valvular Calcifications and Mortality in Hemodialysis Patients. Biomedicines 2024; 13:48. [PMID: 39857632 PMCID: PMC11762509 DOI: 10.3390/biomedicines13010048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2024] [Revised: 12/18/2024] [Accepted: 12/25/2024] [Indexed: 01/27/2025] Open
Abstract
Background/Objectives: Vitamin K deficiency in chronic kidney disease (CKD) could potentially occur due to multiple factors, leading to an increased risk of vascular and valvular calcifications. Vitamin K status can be indirectly assessed by measuring the blood levels of vitamin K-dependent proteins (VKDPs), such as matrix GLA protein (MGP). This study aims to examine the relationship between the levels of inactive MGP (dp-uc MGP) and the presence of valvular calcifications, as well as its association with mortality in hemodialysis patients. Methods: We conducted a single-center study that included 45 CKD G5D patients (hemodialysis for 6 months to 10 years) followed up for 24 months. All patients have been assessed at baseline regarding cardiovascular disease (medical history, echocardiography). Moreover, using standard methods, we determined blood biochemistry, complete blood count, and matrix GLA protein. At 24 months of follow-up, we assessed all-cause mortality and cardiovascular mortality. Results: In the studied hemodialysis patients, mean dp-uc MGP was 3285.93 +/- 2092.85 pmol/L. Patients with valvular calcifications had higher levels of dp-uc MGP compared to those without (4521.08 +/- 2263.82 vs. 2487.53 +/- 1446.94 pmol/L, however not statistically significant). The presence and severity of valvular calcifications were significantly associated with the history of treatment with vitamin K antagonists (p < 0.05). After 24 months of follow-up, we found an all-cause mortality rate of 24.4%. The level of dp-uc MGP was higher in the group of patients that died (3884.81 +/- 2439.20 vs. 3133.09 +/- 1925.26 pmol/L, p > 0.05). Patients with more than one valvular calcification on echocardiography had a significantly higher all-cause mortality risk (p = 0.04). In terms of traditional risk factors, we observed an increased risk of all-cause mortality in patients with a history of diabetes mellitus (p = 0.02) and aortic stenosis (p = 0.01). However, other cardiovascular markers, such as coronary heart disease and ejection fraction < 50%, did not have a statistically significant impact on mortality in our patients. Conclusions: In our study, we found that vitamin K deficiency, measured indirectly using the level of VKDP, especially dp-uc MGP, is a predictor of valvular calcifications. Severe valvular calcifications, aortic stenosis, and the presence of diabetes mellitus are risk factors for all-cause mortality in hemodialysis patients.
Collapse
Affiliation(s)
- Marcel Palamar
- Department of Internal Medicine II—Nephrology University Clinic, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (M.P.); (A.S.); (L.P.); (F.B.)
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
- Deva Emergency County Hospital, 330004 Deva, Romania; (E.G.)
- Dialysis, Fresenius Nephrocare Deva, 330004 Deva, Romania
| | - Iulia Dana Grosu
- Department of Internal Medicine II—Nephrology University Clinic, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (M.P.); (A.S.); (L.P.); (F.B.)
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Adalbert Schiller
- Department of Internal Medicine II—Nephrology University Clinic, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (M.P.); (A.S.); (L.P.); (F.B.)
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Ligia Petrica
- Department of Internal Medicine II—Nephrology University Clinic, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (M.P.); (A.S.); (L.P.); (F.B.)
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Madalina Bodea
- Department of Internal Medicine II—Nephrology University Clinic, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (M.P.); (A.S.); (L.P.); (F.B.)
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | - Alexandru Sircuta
- Department of Internal Medicine II—Nephrology University Clinic, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (M.P.); (A.S.); (L.P.); (F.B.)
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| | | | | | | | - Ionut Golet
- Department of Management, Faculty of Economics and Business Administration, University of the West Timisoara, 300223 Timisoara, Romania
| | - Flaviu Bob
- Department of Internal Medicine II—Nephrology University Clinic, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (M.P.); (A.S.); (L.P.); (F.B.)
- Centre for Molecular Research in Nephrology and Vascular Disease, Faculty of Medicine, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
| |
Collapse
|
3
|
Neofytou IE, Stamou A, Demopoulos A, Roumeliotis S, Zebekakis P, Liakopoulos V, Stamellou E, Dounousi E. Vitamin K for Vascular Calcification in Kidney Patients: Still Alive and Kicking, but Still a Lot to Learn. Nutrients 2024; 16:1798. [PMID: 38931153 PMCID: PMC11206649 DOI: 10.3390/nu16121798] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2024] [Revised: 06/03/2024] [Accepted: 06/05/2024] [Indexed: 06/28/2024] Open
Abstract
Patients with chronic kidney disease (CKD) suffer disproportionately from a high burden of cardiovascular disease, which, despite recent scientific advances, remains partly understood. Vascular calcification (VC) is the result of an ongoing process of misplaced calcium in the inner and medial layers of the arteries, which has emerged as a critical contributor to cardiovascular events in CKD. Beyond its established role in blood clotting and bone health, vitamin K appears crucial in regulating VC via vitamin K-dependent proteins (VKDPs). Among these, the matrix Gla protein (MGP) serves as both a potent inhibitor of VC and a valuable biomarker (in its inactive form) for reflecting circulating vitamin K levels. CKD patients, especially in advanced stages, often present with vitamin K deficiency due to dietary restrictions, medications, and impaired intestinal absorption in the uremic environment. Epidemiological studies confirm a strong association between vitamin K levels, inactive MGP, and increased CVD risk across CKD stages. Based on the promising results of pre-clinical data, an increasing number of clinical trials have investigated the potential benefits of vitamin K supplementation to prevent, delay, or even reverse VC, but the results have remained inconsistent.
Collapse
Affiliation(s)
- Ioannis Eleftherios Neofytou
- 2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece; (I.E.N.); (A.S.); (A.D.); (V.L.)
| | - Aikaterini Stamou
- 2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece; (I.E.N.); (A.S.); (A.D.); (V.L.)
| | - Antonia Demopoulos
- 2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece; (I.E.N.); (A.S.); (A.D.); (V.L.)
| | - Stefanos Roumeliotis
- 2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece; (I.E.N.); (A.S.); (A.D.); (V.L.)
| | - Pantelis Zebekakis
- 1st Department of Internal Medicine, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece;
| | - Vassilios Liakopoulos
- 2nd Department of Nephrology, AHEPA Hospital, Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece; (I.E.N.); (A.S.); (A.D.); (V.L.)
| | - Eleni Stamellou
- Department of Nephrology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece; (E.S.); (E.D.)
- Division of Nephrology and Clinical Immunology, RWTH Aachen University, 52062 Aachen, Germany
| | - Evangelia Dounousi
- Department of Nephrology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece; (E.S.); (E.D.)
| |
Collapse
|
4
|
Fusaro M, Pereira L, Bover J. Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease-Mineral and Bone Disorder in Non-Dialysis Adult Patients. J Clin Med 2023; 12:6306. [PMID: 37834950 PMCID: PMC10573159 DOI: 10.3390/jcm12196306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2023] [Revised: 09/19/2023] [Accepted: 09/27/2023] [Indexed: 10/15/2023] Open
Abstract
Chronic kidney disease (CKD) is a significant public health concern associated with significant morbidity and has become one of the foremost global causes of death in recent years. A frequent comorbidity of CKD is secondary hyperparathyroidism (SHPT), exemplified by high serum parathyroid hormone (PTH) levels. The mineral metabolism disturbances resulting from CKD and progression to SHPT are currently considered part of the definition of chronic kidney disease-mineral and bone disorder (CKD-MBD). However, CKD-MBD does not only include abnormalities in laboratory-measured parameters; it is a complex condition characterized by dysregulation of bone turnover, mineralization, growth and strength, accompanied by vascular or another soft-tissue calcification. Together, this increases the risk of bone fractures, cardiovascular disease, and overall mortality in CKD-MBD patients. Monitoring serum markers is essential in diagnosing SHPT and CKD-MBD, and there are several recognized indicators for prognosis, optimal clinical management and treatment response in late-stage kidney disease patients receiving dialysis. However, far fewer markers have been established for patients with non-dialysis CKD. This review provides an overview of current and emerging markers and tools used in the diagnosis and management of CKD-MBD in non-dialysis adult patients.
Collapse
Affiliation(s)
- Maria Fusaro
- National Research Council (CNR)—Institute of Clinical Physiology (IFC), Via G. Moruzzi 1, 56124 Pisa, Italy
- Department of Medicine, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy
| | - Luciano Pereira
- Institute of Investigation and Innovation in Health, University of Porto, 4200-135 Porto, Portugal
- INEB—National Institute of Biomedical Engineering, University of Porto, 4150-180 Porto, Portugal
- DaVita Kidney Care, 4200-448 Porto, Portugal
- Faculty of Medicine, University of Porto, 4200-250 Porto, Portugal
| | - Jordi Bover
- Nephrology Department, University Hospital Germans Trias i Pujol (HGiTP), 08916 Barcelona, Spain
| |
Collapse
|
5
|
Bellone F, Cinquegrani M, Nicotera R, Carullo N, Casarella A, Presta P, Andreucci M, Squadrito G, Mandraffino G, Prunestì M, Vocca C, De Sarro G, Bolignano D, Coppolino G. Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health. Int J Mol Sci 2022; 23:5282. [PMID: 35563672 PMCID: PMC9099759 DOI: 10.3390/ijms23095282] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Revised: 05/07/2022] [Accepted: 05/07/2022] [Indexed: 12/28/2022] Open
Abstract
Chronic kidney disease (CKD) is commonly associated with vitamin K deficiency. Some of the serious complications of CKD are represented by cardiovascular disease (CVD) and skeletal fragility with an increased risk of morbidity and mortality. A complex pathogenetic link between hormonal and ionic disturbances, bone tissue and metabolism alterations, and vascular calcification (VC) exists and has been defined as chronic kidney disease-mineral and bone disorder (CKD-MBD). Poor vitamin K status seems to have a key role in the progression of CKD, but also in the onset and advance of both bone and cardiovascular complications. Three forms of vitamin K are currently known: vitamin K1 (phylloquinone), vitamin K2 (menaquinone), and vitamin K3 (menadione). Vitamin K plays different roles, including in activating vitamin K-dependent proteins (VKDPs) and in modulating bone metabolism and contributing to the inhibition of VC. This review focuses on the biochemical and functional characteristics of vitamin K vitamers, suggesting this nutrient as a possible marker of kidney, CV, and bone damage in the CKD population and exploring its potential use for promoting health in this clinical setting. Treatment strategies for CKD-associated osteoporosis and CV disease should include vitamin K supplementation. However, further randomized clinical studies are needed to assess the safety and the adequate dosage to prevent these CKD complications.
Collapse
Affiliation(s)
- Federica Bellone
- Department of Clinical and Experimental Medicine, University of Messina, I-98100 Messina, Italy; (F.B.); (M.C.); (G.S.); (G.M.)
| | - Maria Cinquegrani
- Department of Clinical and Experimental Medicine, University of Messina, I-98100 Messina, Italy; (F.B.); (M.C.); (G.S.); (G.M.)
| | - Ramona Nicotera
- Azienda Sanitaria Provinciale di Catanzaro, I-88100 Catanzaro, Italy; (R.N.); (M.P.)
| | - Nazareno Carullo
- Department of Health Sciences, “Magna Graecia” University, I-88100 Catanzaro, Italy; (N.C.); (A.C.); (P.P.); (M.A.); (C.V.); (G.D.S.); (D.B.)
| | - Alessandro Casarella
- Department of Health Sciences, “Magna Graecia” University, I-88100 Catanzaro, Italy; (N.C.); (A.C.); (P.P.); (M.A.); (C.V.); (G.D.S.); (D.B.)
| | - Pierangela Presta
- Department of Health Sciences, “Magna Graecia” University, I-88100 Catanzaro, Italy; (N.C.); (A.C.); (P.P.); (M.A.); (C.V.); (G.D.S.); (D.B.)
| | - Michele Andreucci
- Department of Health Sciences, “Magna Graecia” University, I-88100 Catanzaro, Italy; (N.C.); (A.C.); (P.P.); (M.A.); (C.V.); (G.D.S.); (D.B.)
| | - Giovanni Squadrito
- Department of Clinical and Experimental Medicine, University of Messina, I-98100 Messina, Italy; (F.B.); (M.C.); (G.S.); (G.M.)
| | - Giuseppe Mandraffino
- Department of Clinical and Experimental Medicine, University of Messina, I-98100 Messina, Italy; (F.B.); (M.C.); (G.S.); (G.M.)
| | - Marcello Prunestì
- Azienda Sanitaria Provinciale di Catanzaro, I-88100 Catanzaro, Italy; (R.N.); (M.P.)
| | - Cristina Vocca
- Department of Health Sciences, “Magna Graecia” University, I-88100 Catanzaro, Italy; (N.C.); (A.C.); (P.P.); (M.A.); (C.V.); (G.D.S.); (D.B.)
| | - Giovambattista De Sarro
- Department of Health Sciences, “Magna Graecia” University, I-88100 Catanzaro, Italy; (N.C.); (A.C.); (P.P.); (M.A.); (C.V.); (G.D.S.); (D.B.)
| | - Davide Bolignano
- Department of Health Sciences, “Magna Graecia” University, I-88100 Catanzaro, Italy; (N.C.); (A.C.); (P.P.); (M.A.); (C.V.); (G.D.S.); (D.B.)
| | - Giuseppe Coppolino
- Department of Health Sciences, “Magna Graecia” University, I-88100 Catanzaro, Italy; (N.C.); (A.C.); (P.P.); (M.A.); (C.V.); (G.D.S.); (D.B.)
| |
Collapse
|